Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects - Ronsein, Graziella E.; Vaisar, Tomas; Davidson, W. Sean; Bornfeldt, Karin E.; Probstfield, Jeffrey L.; O’Brien, Kevin D.; Zhao, Xue-Qiao; Heinecke, Jay W. (Arteriosclerosis, thrombosis, and vascular biology, 2021)
Keywords: Adult; Atherosclerosis - blood; Atherosclerosis - drug therapy; Cardiotonic Agents - pharmacology; Cardiotonic Agents - therapeutic use; Cardiovascular Diseases - blood; Cardiovascular Diseases - prevention & control; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Lipoproteins, HDL - blood; Lipoproteins, HDL - chemistry; Male; Middle Aged; Niacin - pharmacology; Niacin - therapeutic use; Proteomics; atherosclerosis; cardioprotection; clusterin; high-density lipoprotein metabolism; lipid metabolism